Global GLP-1-based Therapy Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global GLP-1-based Therapy market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
GLP-1-based therapy involves the use of medications that mimic the actions of glucagon-like peptide-1(GLP-1).They work by stimulating insulin secretion in response to elevated blood sugar levels,inhibiting glucagon release,delaying gastric emptying,and promoting a feeling of fullness.These effects help to lower blood glucose levels,improve glycemic control,and often result in weight loss,which are primarily used to manage type 2 diabetes mellitus and loss weight.
This report is a detailed and comprehensive analysis for global GLP-1-based Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
GLP-1-based therapy involves the use of medications that mimic the actions of glucagon-like peptide-1(GLP-1).They work by stimulating insulin secretion in response to elevated blood sugar levels,inhibiting glucagon release,delaying gastric emptying,and promoting a feeling of fullness.These effects help to lower blood glucose levels,improve glycemic control,and often result in weight loss,which are primarily used to manage type 2 diabetes mellitus and loss weight.
This report is a detailed and comprehensive analysis for global GLP-1-based Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global GLP-1-based Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global GLP-1-based Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global GLP-1-based Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global GLP-1-based Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for GLP-1-based Therapy
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
- This report profiles key players in the global GLP-1-based Therapy market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, Hanson, Shanghai Renhui Biopharmaceutical, Huadong Medicine, Sino Biopharm, etc.
- This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
GLP-1-based Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Injection
- Tablets
- Other
Market segment by Application
- Type 2 Diabetes
- Obesity
Major players covered
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- Sanofi
- GSK
- Hanson
- Shanghai Renhui Biopharmaceutical
- Huadong Medicine
- Sino Biopharm
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
- Chapter 1, to describe GLP-1-based Therapy product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of GLP-1-based Therapy, with price, sales quantity, revenue, and global market share of GLP-1-based Therapy from 2021 to 2026.
- Chapter 3, the GLP-1-based Therapy competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the GLP-1-based Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and GLP-1-based Therapy market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1-based Therapy.
- Chapter 14 and 15, to describe GLP-1-based Therapy sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1-based Therapy Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Injection
1.3.3 Tablets
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1-based Therapy Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Type 2 Diabetes
1.4.3 Obesity
1.5 Global GLP-1-based Therapy Market Size & Forecast
1.5.1 Global GLP-1-based Therapy Consumption Value (2021 & 2025 & 2032)
1.5.2 Global GLP-1-based Therapy Sales Quantity (2021-2032)
1.5.3 Global GLP-1-based Therapy Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1-based Therapy Product and Services
2.1.4 Novo Nordisk GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly GLP-1-based Therapy Product and Services
2.2.4 Eli Lilly GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca GLP-1-based Therapy Product and Services
2.3.4 AstraZeneca GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi GLP-1-based Therapy Product and Services
2.4.4 Sanofi GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Sanofi Recent Developments/Updates
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK GLP-1-based Therapy Product and Services
2.5.4 GSK GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 GSK Recent Developments/Updates
2.6 Hanson
2.6.1 Hanson Details
2.6.2 Hanson Major Business
2.6.3 Hanson GLP-1-based Therapy Product and Services
2.6.4 Hanson GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Hanson Recent Developments/Updates
2.7 Shanghai Renhui Biopharmaceutical
2.7.1 Shanghai Renhui Biopharmaceutical Details
2.7.2 Shanghai Renhui Biopharmaceutical Major Business
2.7.3 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product and Services
2.7.4 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Shanghai Renhui Biopharmaceutical Recent Developments/Updates
2.8 Huadong Medicine
2.8.1 Huadong Medicine Details
2.8.2 Huadong Medicine Major Business
2.8.3 Huadong Medicine GLP-1-based Therapy Product and Services
2.8.4 Huadong Medicine GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Huadong Medicine Recent Developments/Updates
2.9 Sino Biopharm
2.9.1 Sino Biopharm Details
2.9.2 Sino Biopharm Major Business
2.9.3 Sino Biopharm GLP-1-based Therapy Product and Services
2.9.4 Sino Biopharm GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sino Biopharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLP-1-BASED THERAPY BY MANUFACTURER
3.1 Global GLP-1-based Therapy Sales Quantity by Manufacturer (2021-2026)
3.2 Global GLP-1-based Therapy Revenue by Manufacturer (2021-2026)
3.3 Global GLP-1-based Therapy Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of GLP-1-based Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 GLP-1-based Therapy Manufacturer Market Share in 2025
3.4.3 Top 6 GLP-1-based Therapy Manufacturer Market Share in 2025
3.5 GLP-1-based Therapy Market: Overall Company Footprint Analysis
3.5.1 GLP-1-based Therapy Market: Region Footprint
3.5.2 GLP-1-based Therapy Market: Company Product Type Footprint
3.5.3 GLP-1-based Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global GLP-1-based Therapy Market Size by Region
4.1.1 Global GLP-1-based Therapy Sales Quantity by Region (2021-2032)
4.1.2 Global GLP-1-based Therapy Consumption Value by Region (2021-2032)
4.1.3 Global GLP-1-based Therapy Average Price by Region (2021-2032)
4.2 North America GLP-1-based Therapy Consumption Value (2021-2032)
4.3 Europe GLP-1-based Therapy Consumption Value (2021-2032)
4.4 Asia-Pacific GLP-1-based Therapy Consumption Value (2021-2032)
4.5 South America GLP-1-based Therapy Consumption Value (2021-2032)
4.6 Middle East & Africa GLP-1-based Therapy Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global GLP-1-based Therapy Sales Quantity by Type (2021-2032)
5.2 Global GLP-1-based Therapy Consumption Value by Type (2021-2032)
5.3 Global GLP-1-based Therapy Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global GLP-1-based Therapy Sales Quantity by Application (2021-2032)
6.2 Global GLP-1-based Therapy Consumption Value by Application (2021-2032)
6.3 Global GLP-1-based Therapy Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America GLP-1-based Therapy Sales Quantity by Type (2021-2032)
7.2 North America GLP-1-based Therapy Sales Quantity by Application (2021-2032)
7.3 North America GLP-1-based Therapy Market Size by Country
7.3.1 North America GLP-1-based Therapy Sales Quantity by Country (2021-2032)
7.3.2 North America GLP-1-based Therapy Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe GLP-1-based Therapy Sales Quantity by Type (2021-2032)
8.2 Europe GLP-1-based Therapy Sales Quantity by Application (2021-2032)
8.3 Europe GLP-1-based Therapy Market Size by Country
8.3.1 Europe GLP-1-based Therapy Sales Quantity by Country (2021-2032)
8.3.2 Europe GLP-1-based Therapy Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific GLP-1-based Therapy Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific GLP-1-based Therapy Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific GLP-1-based Therapy Market Size by Region
9.3.1 Asia-Pacific GLP-1-based Therapy Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific GLP-1-based Therapy Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America GLP-1-based Therapy Sales Quantity by Type (2021-2032)
10.2 South America GLP-1-based Therapy Sales Quantity by Application (2021-2032)
10.3 South America GLP-1-based Therapy Market Size by Country
10.3.1 South America GLP-1-based Therapy Sales Quantity by Country (2021-2032)
10.3.2 South America GLP-1-based Therapy Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa GLP-1-based Therapy Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa GLP-1-based Therapy Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa GLP-1-based Therapy Market Size by Country
11.3.1 Middle East & Africa GLP-1-based Therapy Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa GLP-1-based Therapy Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 GLP-1-based Therapy Market Drivers
12.2 GLP-1-based Therapy Market Restraints
12.3 GLP-1-based Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of GLP-1-based Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1-based Therapy
13.3 GLP-1-based Therapy Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1-based Therapy Typical Distributors
14.3 GLP-1-based Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1-based Therapy Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Injection
1.3.3 Tablets
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1-based Therapy Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Type 2 Diabetes
1.4.3 Obesity
1.5 Global GLP-1-based Therapy Market Size & Forecast
1.5.1 Global GLP-1-based Therapy Consumption Value (2021 & 2025 & 2032)
1.5.2 Global GLP-1-based Therapy Sales Quantity (2021-2032)
1.5.3 Global GLP-1-based Therapy Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1-based Therapy Product and Services
2.1.4 Novo Nordisk GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly GLP-1-based Therapy Product and Services
2.2.4 Eli Lilly GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca GLP-1-based Therapy Product and Services
2.3.4 AstraZeneca GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi GLP-1-based Therapy Product and Services
2.4.4 Sanofi GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Sanofi Recent Developments/Updates
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK GLP-1-based Therapy Product and Services
2.5.4 GSK GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 GSK Recent Developments/Updates
2.6 Hanson
2.6.1 Hanson Details
2.6.2 Hanson Major Business
2.6.3 Hanson GLP-1-based Therapy Product and Services
2.6.4 Hanson GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Hanson Recent Developments/Updates
2.7 Shanghai Renhui Biopharmaceutical
2.7.1 Shanghai Renhui Biopharmaceutical Details
2.7.2 Shanghai Renhui Biopharmaceutical Major Business
2.7.3 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product and Services
2.7.4 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Shanghai Renhui Biopharmaceutical Recent Developments/Updates
2.8 Huadong Medicine
2.8.1 Huadong Medicine Details
2.8.2 Huadong Medicine Major Business
2.8.3 Huadong Medicine GLP-1-based Therapy Product and Services
2.8.4 Huadong Medicine GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Huadong Medicine Recent Developments/Updates
2.9 Sino Biopharm
2.9.1 Sino Biopharm Details
2.9.2 Sino Biopharm Major Business
2.9.3 Sino Biopharm GLP-1-based Therapy Product and Services
2.9.4 Sino Biopharm GLP-1-based Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sino Biopharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLP-1-BASED THERAPY BY MANUFACTURER
3.1 Global GLP-1-based Therapy Sales Quantity by Manufacturer (2021-2026)
3.2 Global GLP-1-based Therapy Revenue by Manufacturer (2021-2026)
3.3 Global GLP-1-based Therapy Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of GLP-1-based Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 GLP-1-based Therapy Manufacturer Market Share in 2025
3.4.3 Top 6 GLP-1-based Therapy Manufacturer Market Share in 2025
3.5 GLP-1-based Therapy Market: Overall Company Footprint Analysis
3.5.1 GLP-1-based Therapy Market: Region Footprint
3.5.2 GLP-1-based Therapy Market: Company Product Type Footprint
3.5.3 GLP-1-based Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global GLP-1-based Therapy Market Size by Region
4.1.1 Global GLP-1-based Therapy Sales Quantity by Region (2021-2032)
4.1.2 Global GLP-1-based Therapy Consumption Value by Region (2021-2032)
4.1.3 Global GLP-1-based Therapy Average Price by Region (2021-2032)
4.2 North America GLP-1-based Therapy Consumption Value (2021-2032)
4.3 Europe GLP-1-based Therapy Consumption Value (2021-2032)
4.4 Asia-Pacific GLP-1-based Therapy Consumption Value (2021-2032)
4.5 South America GLP-1-based Therapy Consumption Value (2021-2032)
4.6 Middle East & Africa GLP-1-based Therapy Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global GLP-1-based Therapy Sales Quantity by Type (2021-2032)
5.2 Global GLP-1-based Therapy Consumption Value by Type (2021-2032)
5.3 Global GLP-1-based Therapy Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global GLP-1-based Therapy Sales Quantity by Application (2021-2032)
6.2 Global GLP-1-based Therapy Consumption Value by Application (2021-2032)
6.3 Global GLP-1-based Therapy Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America GLP-1-based Therapy Sales Quantity by Type (2021-2032)
7.2 North America GLP-1-based Therapy Sales Quantity by Application (2021-2032)
7.3 North America GLP-1-based Therapy Market Size by Country
7.3.1 North America GLP-1-based Therapy Sales Quantity by Country (2021-2032)
7.3.2 North America GLP-1-based Therapy Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe GLP-1-based Therapy Sales Quantity by Type (2021-2032)
8.2 Europe GLP-1-based Therapy Sales Quantity by Application (2021-2032)
8.3 Europe GLP-1-based Therapy Market Size by Country
8.3.1 Europe GLP-1-based Therapy Sales Quantity by Country (2021-2032)
8.3.2 Europe GLP-1-based Therapy Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific GLP-1-based Therapy Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific GLP-1-based Therapy Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific GLP-1-based Therapy Market Size by Region
9.3.1 Asia-Pacific GLP-1-based Therapy Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific GLP-1-based Therapy Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America GLP-1-based Therapy Sales Quantity by Type (2021-2032)
10.2 South America GLP-1-based Therapy Sales Quantity by Application (2021-2032)
10.3 South America GLP-1-based Therapy Market Size by Country
10.3.1 South America GLP-1-based Therapy Sales Quantity by Country (2021-2032)
10.3.2 South America GLP-1-based Therapy Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa GLP-1-based Therapy Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa GLP-1-based Therapy Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa GLP-1-based Therapy Market Size by Country
11.3.1 Middle East & Africa GLP-1-based Therapy Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa GLP-1-based Therapy Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 GLP-1-based Therapy Market Drivers
12.2 GLP-1-based Therapy Market Restraints
12.3 GLP-1-based Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of GLP-1-based Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1-based Therapy
13.3 GLP-1-based Therapy Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1-based Therapy Typical Distributors
14.3 GLP-1-based Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global GLP-1-based Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global GLP-1-based Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1-based Therapy Product and Services
Table 6. Novo Nordisk GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly GLP-1-based Therapy Product and Services
Table 11. Eli Lilly GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca GLP-1-based Therapy Product and Services
Table 16. AstraZeneca GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi GLP-1-based Therapy Product and Services
Table 21. Sanofi GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Sanofi Recent Developments/Updates
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK GLP-1-based Therapy Product and Services
Table 26. GSK GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. GSK Recent Developments/Updates
Table 28. Hanson Basic Information, Manufacturing Base and Competitors
Table 29. Hanson Major Business
Table 30. Hanson GLP-1-based Therapy Product and Services
Table 31. Hanson GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Hanson Recent Developments/Updates
Table 33. Shanghai Renhui Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai Renhui Biopharmaceutical Major Business
Table 35. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product and Services
Table 36. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Shanghai Renhui Biopharmaceutical Recent Developments/Updates
Table 38. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 39. Huadong Medicine Major Business
Table 40. Huadong Medicine GLP-1-based Therapy Product and Services
Table 41. Huadong Medicine GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Huadong Medicine Recent Developments/Updates
Table 43. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 44. Sino Biopharm Major Business
Table 45. Sino Biopharm GLP-1-based Therapy Product and Services
Table 46. Sino Biopharm GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Sino Biopharm Recent Developments/Updates
Table 48. Global GLP-1-based Therapy Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 49. Global GLP-1-based Therapy Revenue by Manufacturer (2021-2026) & (USD Million)
Table 50. Global GLP-1-based Therapy Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 51. Market Position of Manufacturers in GLP-1-based Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 52. Head Office and GLP-1-based Therapy Production Site of Key Manufacturer
Table 53. GLP-1-based Therapy Market: Company Product Type Footprint
Table 54. GLP-1-based Therapy Market: Company Product Application Footprint
Table 55. GLP-1-based Therapy New Market Entrants and Barriers to Market Entry
Table 56. GLP-1-based Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global GLP-1-based Therapy Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 58. Global GLP-1-based Therapy Sales Quantity by Region (2021-2026) & (K Units)
Table 59. Global GLP-1-based Therapy Sales Quantity by Region (2027-2032) & (K Units)
Table 60. Global GLP-1-based Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 61. Global GLP-1-based Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 62. Global GLP-1-based Therapy Average Price by Region (2021-2026) & (US$/Unit)
Table 63. Global GLP-1-based Therapy Average Price by Region (2027-2032) & (US$/Unit)
Table 64. Global GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 65. Global GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 66. Global GLP-1-based Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 67. Global GLP-1-based Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 68. Global GLP-1-based Therapy Average Price by Type (2021-2026) & (US$/Unit)
Table 69. Global GLP-1-based Therapy Average Price by Type (2027-2032) & (US$/Unit)
Table 70. Global GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 71. Global GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 72. Global GLP-1-based Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 73. Global GLP-1-based Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 74. Global GLP-1-based Therapy Average Price by Application (2021-2026) & (US$/Unit)
Table 75. Global GLP-1-based Therapy Average Price by Application (2027-2032) & (US$/Unit)
Table 76. North America GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 77. North America GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 78. North America GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 79. North America GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 80. North America GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 81. North America GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 82. North America GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 83. North America GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Europe GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 85. Europe GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 86. Europe GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 87. Europe GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 88. Europe GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 89. Europe GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 90. Europe GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Europe GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Asia-Pacific GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 93. Asia-Pacific GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 94. Asia-Pacific GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 95. Asia-Pacific GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 96. Asia-Pacific GLP-1-based Therapy Sales Quantity by Region (2021-2026) & (K Units)
Table 97. Asia-Pacific GLP-1-based Therapy Sales Quantity by Region (2027-2032) & (K Units)
Table 98. Asia-Pacific GLP-1-based Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 99. Asia-Pacific GLP-1-based Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 100. South America GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 101. South America GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 102. South America GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 103. South America GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 104. South America GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 105. South America GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 106. South America GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 107. South America GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Middle East & Africa GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 109. Middle East & Africa GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 110. Middle East & Africa GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 111. Middle East & Africa GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 112. Middle East & Africa GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 113. Middle East & Africa GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 114. Middle East & Africa GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 115. Middle East & Africa GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 116. GLP-1-based Therapy Raw Material
Table 117. Key Manufacturers of GLP-1-based Therapy Raw Materials
Table 118. GLP-1-based Therapy Typical Distributors
Table 119. GLP-1-based Therapy Typical Customers
Table 1. Global GLP-1-based Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global GLP-1-based Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1-based Therapy Product and Services
Table 6. Novo Nordisk GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly GLP-1-based Therapy Product and Services
Table 11. Eli Lilly GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca GLP-1-based Therapy Product and Services
Table 16. AstraZeneca GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi GLP-1-based Therapy Product and Services
Table 21. Sanofi GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Sanofi Recent Developments/Updates
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK GLP-1-based Therapy Product and Services
Table 26. GSK GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. GSK Recent Developments/Updates
Table 28. Hanson Basic Information, Manufacturing Base and Competitors
Table 29. Hanson Major Business
Table 30. Hanson GLP-1-based Therapy Product and Services
Table 31. Hanson GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Hanson Recent Developments/Updates
Table 33. Shanghai Renhui Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai Renhui Biopharmaceutical Major Business
Table 35. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product and Services
Table 36. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Shanghai Renhui Biopharmaceutical Recent Developments/Updates
Table 38. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 39. Huadong Medicine Major Business
Table 40. Huadong Medicine GLP-1-based Therapy Product and Services
Table 41. Huadong Medicine GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Huadong Medicine Recent Developments/Updates
Table 43. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 44. Sino Biopharm Major Business
Table 45. Sino Biopharm GLP-1-based Therapy Product and Services
Table 46. Sino Biopharm GLP-1-based Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Sino Biopharm Recent Developments/Updates
Table 48. Global GLP-1-based Therapy Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 49. Global GLP-1-based Therapy Revenue by Manufacturer (2021-2026) & (USD Million)
Table 50. Global GLP-1-based Therapy Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 51. Market Position of Manufacturers in GLP-1-based Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 52. Head Office and GLP-1-based Therapy Production Site of Key Manufacturer
Table 53. GLP-1-based Therapy Market: Company Product Type Footprint
Table 54. GLP-1-based Therapy Market: Company Product Application Footprint
Table 55. GLP-1-based Therapy New Market Entrants and Barriers to Market Entry
Table 56. GLP-1-based Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global GLP-1-based Therapy Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 58. Global GLP-1-based Therapy Sales Quantity by Region (2021-2026) & (K Units)
Table 59. Global GLP-1-based Therapy Sales Quantity by Region (2027-2032) & (K Units)
Table 60. Global GLP-1-based Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 61. Global GLP-1-based Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 62. Global GLP-1-based Therapy Average Price by Region (2021-2026) & (US$/Unit)
Table 63. Global GLP-1-based Therapy Average Price by Region (2027-2032) & (US$/Unit)
Table 64. Global GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 65. Global GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 66. Global GLP-1-based Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 67. Global GLP-1-based Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 68. Global GLP-1-based Therapy Average Price by Type (2021-2026) & (US$/Unit)
Table 69. Global GLP-1-based Therapy Average Price by Type (2027-2032) & (US$/Unit)
Table 70. Global GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 71. Global GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 72. Global GLP-1-based Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 73. Global GLP-1-based Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 74. Global GLP-1-based Therapy Average Price by Application (2021-2026) & (US$/Unit)
Table 75. Global GLP-1-based Therapy Average Price by Application (2027-2032) & (US$/Unit)
Table 76. North America GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 77. North America GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 78. North America GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 79. North America GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 80. North America GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 81. North America GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 82. North America GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 83. North America GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Europe GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 85. Europe GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 86. Europe GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 87. Europe GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 88. Europe GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 89. Europe GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 90. Europe GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Europe GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Asia-Pacific GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 93. Asia-Pacific GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 94. Asia-Pacific GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 95. Asia-Pacific GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 96. Asia-Pacific GLP-1-based Therapy Sales Quantity by Region (2021-2026) & (K Units)
Table 97. Asia-Pacific GLP-1-based Therapy Sales Quantity by Region (2027-2032) & (K Units)
Table 98. Asia-Pacific GLP-1-based Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 99. Asia-Pacific GLP-1-based Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 100. South America GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 101. South America GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 102. South America GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 103. South America GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 104. South America GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 105. South America GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 106. South America GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 107. South America GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Middle East & Africa GLP-1-based Therapy Sales Quantity by Type (2021-2026) & (K Units)
Table 109. Middle East & Africa GLP-1-based Therapy Sales Quantity by Type (2027-2032) & (K Units)
Table 110. Middle East & Africa GLP-1-based Therapy Sales Quantity by Application (2021-2026) & (K Units)
Table 111. Middle East & Africa GLP-1-based Therapy Sales Quantity by Application (2027-2032) & (K Units)
Table 112. Middle East & Africa GLP-1-based Therapy Sales Quantity by Country (2021-2026) & (K Units)
Table 113. Middle East & Africa GLP-1-based Therapy Sales Quantity by Country (2027-2032) & (K Units)
Table 114. Middle East & Africa GLP-1-based Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 115. Middle East & Africa GLP-1-based Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 116. GLP-1-based Therapy Raw Material
Table 117. Key Manufacturers of GLP-1-based Therapy Raw Materials
Table 118. GLP-1-based Therapy Typical Distributors
Table 119. GLP-1-based Therapy Typical Customers
LIST OF FIGURES
Figure 1. GLP-1-based Therapy Picture
Figure 2. Global GLP-1-based Therapy Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global GLP-1-based Therapy Revenue Market Share by Type in 2025
Figure 4. Injection Examples
Figure 5. Tablets Examples
Figure 6. Other Examples
Figure 7. Global GLP-1-based Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global GLP-1-based Therapy Revenue Market Share by Application in 2025
Figure 9. Type 2 Diabetes Examples
Figure 10. Obesity Examples
Figure 11. Global GLP-1-based Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global GLP-1-based Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global GLP-1-based Therapy Sales Quantity (2021-2032) & (K Units)
Figure 14. Global GLP-1-based Therapy Price (2021-2032) & (US$/Unit)
Figure 15. Global GLP-1-based Therapy Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global GLP-1-based Therapy Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of GLP-1-based Therapy by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 GLP-1-based Therapy Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 GLP-1-based Therapy Manufacturer (Revenue) Market Share in 2025
Figure 20. Global GLP-1-based Therapy Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global GLP-1-based Therapy Consumption Value Market Share by Region (2021-2032)
Figure 22. North America GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 25. South America GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 27. Global GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global GLP-1-based Therapy Consumption Value Market Share by Type (2021-2032)
Figure 29. Global GLP-1-based Therapy Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global GLP-1-based Therapy Revenue Market Share by Application (2021-2032)
Figure 32. Global GLP-1-based Therapy Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 37. United States GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 45. France GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific GLP-1-based Therapy Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific GLP-1-based Therapy Consumption Value Market Share by Region (2021-2032)
Figure 53. China GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 56. India GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 59. South America GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 73. GLP-1-based Therapy Market Drivers
Figure 74. GLP-1-based Therapy Market Restraints
Figure 75. GLP-1-based Therapy Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of GLP-1-based Therapy in 2025
Figure 78. Manufacturing Process Analysis of GLP-1-based Therapy
Figure 79. GLP-1-based Therapy Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. GLP-1-based Therapy Picture
Figure 2. Global GLP-1-based Therapy Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global GLP-1-based Therapy Revenue Market Share by Type in 2025
Figure 4. Injection Examples
Figure 5. Tablets Examples
Figure 6. Other Examples
Figure 7. Global GLP-1-based Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global GLP-1-based Therapy Revenue Market Share by Application in 2025
Figure 9. Type 2 Diabetes Examples
Figure 10. Obesity Examples
Figure 11. Global GLP-1-based Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global GLP-1-based Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global GLP-1-based Therapy Sales Quantity (2021-2032) & (K Units)
Figure 14. Global GLP-1-based Therapy Price (2021-2032) & (US$/Unit)
Figure 15. Global GLP-1-based Therapy Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global GLP-1-based Therapy Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of GLP-1-based Therapy by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 GLP-1-based Therapy Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 GLP-1-based Therapy Manufacturer (Revenue) Market Share in 2025
Figure 20. Global GLP-1-based Therapy Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global GLP-1-based Therapy Consumption Value Market Share by Region (2021-2032)
Figure 22. North America GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 25. South America GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 27. Global GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global GLP-1-based Therapy Consumption Value Market Share by Type (2021-2032)
Figure 29. Global GLP-1-based Therapy Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global GLP-1-based Therapy Revenue Market Share by Application (2021-2032)
Figure 32. Global GLP-1-based Therapy Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 37. United States GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 45. France GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific GLP-1-based Therapy Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific GLP-1-based Therapy Consumption Value Market Share by Region (2021-2032)
Figure 53. China GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 56. India GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 59. South America GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa GLP-1-based Therapy Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa GLP-1-based Therapy Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa GLP-1-based Therapy Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa GLP-1-based Therapy Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa GLP-1-based Therapy Consumption Value (2021-2032) & (USD Million)
Figure 73. GLP-1-based Therapy Market Drivers
Figure 74. GLP-1-based Therapy Market Restraints
Figure 75. GLP-1-based Therapy Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of GLP-1-based Therapy in 2025
Figure 78. Manufacturing Process Analysis of GLP-1-based Therapy
Figure 79. GLP-1-based Therapy Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
